Dyslipidemia is associated with monocyte lipid metabolic reprogramming in Guillain–Barré syndrome
monocytes. The transcription factor CEBPB is associated with this phenotypic conversion by regulating lipid metabolism and differentiation genes, revealing molecular targets for precise GBS diagnosis and therapy.
Authors
- Shuanghong Sun
- Di Zhong
- Hao Wang (ORCID: https://orcid.org/0000-0001-6881-9977)
- Feihong Jia
- Yuehua Chen (ORCID: https://orcid.org/0009-0006-1343-7449)
- Jihe Song
- Meng Li
- Hongping Chen
Institutions
- Harbin Medical University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-04-13
- DOI
- https://doi.org/10.3389/fneur.2026.1797582
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00